MY QUESTION d) WAS: d) PLEASE CLARIFY, AND IF POSSIBLE, EXPLAIN: 1) MY CLASSIFICATION BEFORE SURGERY? 2) MY...

QUESTION D: Your Risk Classification Across All Time Points

Complete Risk Stratification Analysis (NCCN, AUA, EAU Guidelines)

---

D1: Your Classification BEFORE Surgery

Pre-Operative Risk Assessment (April 2025)

Your Pre-Op Clinical Data:

CLINICAL PARAMETERS:

PSA: 6.8 ng/mL
Digital Rectal Exam (DRE): T1c (not palpable, PSA-detected)
Biopsy Gleason: 3+4=7 (Grade Group 2)
Biopsy Extent: 2 of 12 cores positive (16.7%)
Tumor Volume: Estimated <5% of prostate
Clinical Stage: cT1c N0 M0

---

D1A: NCCN Risk Classification (Pre-Op)

According to NCCN Guidelines (2024):

NCCN RISK STRATIFICATION SYSTEM:

Five Risk Categories:
1. Very Low-Risk
2. Low-Risk
3. Intermediate-Risk (Favorable or Unfavorable)
4. High-Risk
5. Very High-Risk

YOUR PRE-OPERATIVE CLASSIFICATION:

PSA: 6.8 ng/mL
→ Exceeds low-risk threshold (<10 ng/mL) ✓
→ Below high-risk threshold (>20 ng/mL) ✓

Gleason: 3+4=7 (Grade Group 2)
→ Exceeds very low-risk (Grade Group 1) ✗
→ Below high-risk (Grade Group 4-5) ✓

Clinical Stage: cT1c
→ Organ-confined ✓
→ Not palpable ✓

NCCN CLASSIFICATION: INTERMEDIATE-RISK (FAVORABLE)

Rationale:
• PSA 6.8 ng/mL = Intermediate range
• Gleason 7 = Intermediate grade
• cT1c = Organ-confined
• No high-risk features
• Classified as "Favorable Intermediate-Risk"

---

D1B: AUA Risk Classification (Pre-Op)

According to AUA Guidelines (2023):

AUA RISK STRATIFICATION SYSTEM:

Three Risk Categories:
1. Low-Risk
2. Intermediate-Risk
3. High-Risk

YOUR PRE-OPERATIVE CLASSIFICATION:

PSA: 6.8 ng/mL
→ <10 ng/mL (low-risk threshold) ✓

Gleason: 3+4=7 (Grade Group 2)
→ Grade Group 2 (intermediate) ✓

Clinical Stage: cT1c
→ Organ-confined ✓

AUA CLASSIFICATION: INTERMEDIATE-RISK

Rationale:
• PSA 6.8 ng/mL = Meets intermediate criterion
• Gleason 7 = Meets intermediate criterion
• cT1c = Organ-confined
• Presence of ANY intermediate-risk feature = Intermediate-Risk category

---

D1C: EAU Risk Classification (Pre-Op)

According to European Urology Association Guidelines (2023):

EAU RISK STRATIFICATION SYSTEM:

Four Risk Categories:
1. Low-Risk
2. Intermediate-Risk (Favorable or Unfavorable)
3. High-Risk
4. Very High-Risk

YOUR PRE-OPERATIVE CLASSIFICATION:

PSA: 6.8 ng/mL
→ <10 ng/mL (low-risk threshold) ✓

Gleason: 3+4=7 (Grade Group 2)
→ Grade Group 2 (intermediate) ✓

Clinical Stage: cT1c
→ Organ-confined ✓

EAU CLASSIFICATION: INTERMEDIATE-RISK (FAVORABLE)

Rationale:
• PSA 6.8 ng/mL = Favorable intermediate criterion
• Gleason 7 = Intermediate grade
• cT1c = Organ-confined
• No unfavorable intermediate-risk features
• Classified as "Favorable Intermediate-Risk"

---

D1D: Summary - Pre-Operative Classification

PRE-OPERATIVE RISK CLASSIFICATION (April 2025):

NCCN:        INTERMEDIATE-RISK (FAVORABLE)
AUA:         INTERMEDIATE-RISK
EAU:         INTERMEDIATE-RISK (FAVORABLE)

CONSENSUS:   FAVORABLE INTERMEDIATE-RISK

CLINICAL IMPLICATIONS:
✓ Radical prostatectomy recommended
✓ Pelvic lymph node dissection recommended
✓ Adjuvant therapy NOT routinely recommended
✓ Active surveillance NOT appropriate
✓ 10-year prostate cancer-specific mortality: 2-5%

---

---

D2: Your Classification AFTER Surgery (Pathological Stage)

Post-Operative Risk Assessment (May 2025 - Pathology Results)

Your Pathological Data:

PATHOLOGICAL PARAMETERS:

Surgical Specimen:
• Prostate weight: 42 grams
• Tumor location: Left apex and mid-gland
• Tumor extent: Focal involvement

Gleason Score: 3+4=7 (Grade Group 2)
• Primary pattern (3): 70%
• Secondary pattern (4): 30%

Tumor Stage: pT2c
• Confined to prostate ✓
• Bilateral involvement (left > right)
• No extraprostatic extension ✗
• No seminal vesicle invasion ✗

Margins: Close apical (focal positive)
• Apical margin: Close/focal positive
• Other margins: Negative

Lymph Nodes: pN0
• No lymph node involvement

Perineural Invasion: Present
• Focal perineural invasion noted

Tumor Volume: <5% each lobe
• Low tumor burden

---

D2A: NCCN Risk Classification (Post-Op, Before PSA Response)

According to NCCN Guidelines (2024):

NCCN PATHOLOGICAL RISK STRATIFICATION:

Post-operative risk assessment uses:
• Pathological stage (pT, pN, pM)
• Pathological Gleason grade
• Surgical margin status
• PSA nadir (when available)

YOUR POST-OPERATIVE CLASSIFICATION:

Pathological Stage: pT2c
→ Organ-confined ✓
→ Bilateral involvement ✓

Gleason: 3+4=7 (Grade Group 2)
→ Intermediate grade ✓

Margins: Close apical (focal positive)
→ Unfavorable feature ✗

Lymph Nodes: pN0
→ No involvement ✓

NCCN CLASSIFICATION: INTERMEDIATE-RISK (UNFAVORABLE)

Rationale:
• pT2c = Intermediate-risk stage
• Gleason 7 = Intermediate grade
• Close/positive margin = Unfavorable feature
• Presence of unfavorable feature = Unfavorable Intermediate-Risk
• PSA nadir not yet available for reclassification

CLINICAL IMPLICATIONS (Before PSA Response):
• Adjuvant radiation therapy: Consider
• Adjuvant hormone therapy: Consider
• Close PSA monitoring: Essential
• Salvage therapy: May be needed if PSA rises

---

D2B: AUA Risk Classification (Post-Op, Before PSA Response)

According to AUA Guidelines (2023):

AUA PATHOLOGICAL RISK STRATIFICATION:

Post-operative risk assessment uses:
• Pathological stage
• Pathological Gleason grade
• Surgical margin status

YOUR POST-OPERATIVE CLASSIFICATION:

Pathological Stage: pT2c
→ Organ-confined ✓

Gleason: 3+4=7 (Grade Group 2)
→ Intermediate grade ✓

Margins: Close apical (focal positive)
→ Unfavorable feature ✗

AUA CLASSIFICATION: INTERMEDIATE-RISK (UNFAVORABLE)

Rationale:
• pT2c = Intermediate-risk stage
•